Mortality Clinical Trial
Official title:
Randomised Trial of Vitamin A Supplementation Given With Routine Childhood Vaccines at National Immunisation Days
Vitamin A supplementation (VAS) is important for the immune system and may interact with
different childhood vaccinations. We have hypothesized that the improved survival after VAS
may depend on vitamin A amplifying the non-specific immune modulation induced by
vaccinations.
In the present study we used information collected in connection with a national vitamin A
campaign in Guinea-Bissau during which different doses of VAS was provided together with
missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential
interactions between VAS and vaccine type.
Vitamin A supplementation (VAS) acts as an adjuvant to vaccines, and VAS has been shown to
enhance both cellular and humoral immune responses in animals and in humans. Routine
childhood vaccinations have recently been shown to have important non-targeted effects on
mortality, i.e. effects that cannot be explained merely by the prevention of the targeted
disease. We have hypothesized that the improved survival after VAS may depend not only on
the prevention of vitamin A deficiency, but also on vitamin A amplifying the non-specific
immune modulation induced by routine vaccinations.
In the present study we used information collected in connection with a national vitamin A
campaign in Guinea-Bissau during which different doses of VAS was provided together with
missing doses of DTP, OPV, and measles vaccines. We aimed to study the potential
interactions between VAS and vaccine type.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04092465 -
Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT)
|
||
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Not yet recruiting |
NCT04900610 -
The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis
|
N/A | |
Completed |
NCT04149873 -
Effectness of Treatment With Mechanical Insufflation-Exsufflation
|
N/A | |
Completed |
NCT05905042 -
Follow-up of Recovery Condition in Survivors of Acute Respiratory Distress Syndrome
|
||
Completed |
NCT00527774 -
Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients
|
N/A | |
Completed |
NCT00518856 -
Lufwanyama Neonatal Survival Project
|
N/A | |
Completed |
NCT06408636 -
Prognostic Role of LA Strain in Acute Myocardial Infarction
|
||
Completed |
NCT06051526 -
The African Critical Illness Outcomes Study
|
||
Recruiting |
NCT05055089 -
Short- and Medium-term Results of New Generation Aortic
|
||
Active, not recruiting |
NCT04132492 -
AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients
|
||
Completed |
NCT03885206 -
Effectiveness and Clinical Outcomes of Municipal Acute Wards Versus a General Hospital
|
N/A | |
Completed |
NCT05573659 -
Capillary Refill Time Calculated With a Video-assisted Method Has a Better Reproducibility Than Visual Method in Critically Ill Patients
|
N/A | |
Withdrawn |
NCT03245658 -
The Effect of Cannabis in Pancreatic Cancer
|
Phase 2 | |
Recruiting |
NCT04094428 -
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
|
||
Completed |
NCT01631799 -
Outcome of Patients After Total Knee Replacement: A Comparison of Femoral Nerve Block and Epidural Anesthesia
|
N/A | |
Completed |
NCT00244673 -
Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination
|
Phase 4 | |
Completed |
NCT03378843 -
Spermidine Intake and All-cause Mortality
|
N/A | |
Recruiting |
NCT04424511 -
Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali
|
Phase 3 |